- Home
- / Apogenix
Apogenix
Total Funding
$55.7 M
Apogenix Summary
Company Summary
- Overview
- Apogenixis a clinical-stage biopharmaceutical company. It develops protein therapeutics for the treatment of solid tumors and malignant hematological diseases.
- Type
- Private
- Status
- Active
- Founded
- 2005
- HQ
- Heidelberg, DE | view all locations
- Website
- https://apogenix.com/en/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Heidelberg, Baden-Württemberg HQ
Germany
Im Neuenheimer Feld 584
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026